Why the study?
Does telmisartan 80 mg alone or with stepwise addition of HCTZ and/or other antihypertensives improve diastolic blood pressure control in patients with mild-to-moderate hypertension?
Population
489 patients with mild-to-moderate hypertension who completed a preceding 6-week randomized trial
Design
Cohort, open-label
Follow-up
maximal 1-year
Authors
Loading...
Observational data link telmisartan monotherapy to higher DBP control than add-on regimens; leaves open whether stepwise titration improves outcomes in trials.
Does telmisartan 80 mg alone or with stepwise addition of HCTZ and/or other antihypertensives improve diastolic blood pressure control in patients with mild-to-moderate hypertension?
Telmisartan 80 mg, alone or with stepwise addition of HCTZ or other antihypertensives, maintains long-term blood pressure control in patients with mild-to-moderate hypertension.
Neutel et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: